Allscripts Healthcare Solutions Stock News

Allscripts Healthcare Solutions, Inc.'s (MDRX) CEO Paul Black on Q4 2021 Results - Earnings Call Transcript

AllScripts (MDRX) delivered earnings and revenue surprises of 154.84% and 0.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Allscripts Healthcare Solutions press release (NASDAQ:MDRX): Q4 Non-GAAP EPS of $0.79 beats by $0.47.Revenue of $391.7M (+1.4% Y/Y) beats by $1.07M.Shares +4.03%.

CHICAGO--(BUSINESS WIRE)---- $MDRX--Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and twelve months ended December 31, 2021. Bookings(1) were $219 million in the fourth quarter of 2021. This result compares with $181 million in the fourth quarter of 2020. Contract revenue backlog totaled $3.8 billion as of December 31, 2021. Fourth quarter 2021 revenue was $392 million compared with $386 million in the fourth quarter of 2020. On a GAAP bas

Allscripts Healthcare Solutions (NASDAQ:MDRX) is scheduled to announce Q4 earnings results on Thursday, February 24th, after market close.The consensus EPS Estimate is $0.32 (+10.3%…

Investors continue to be optimistic about BD (BDX) owing to its slew of regulatory approvals and strategic deals.

DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect strong segmental performance.

In terms of COVID-19 NGS revenues, Fulgent Genetics (FLGT) is expected to have witnessed a rise in testing volume on increased demand through the Q4 months.

NextGen (NXGN) expects to deliver better insights into patient health history with its latest collaboration with Verato.

WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Digital health technology is designed to provide patients new method of healthcare system. This system includes concepts for saving time, boosting accuracy and cost efficiency to manage illness, health risks and promote wellness. Digital health, or digital healthcare, is a broad, multidisciplinary concept that includes concepts from an intersection between technology and healthcare. Digital health applies digital transformation to the healthcare field, incorporating software, hardware and services. These enhanced capabilities of digital health technology are expected to generate revenue in coming years, states Vantage Market Research, in a report, titled " Digital Health Market by Technology (Telehealthcare, mHealth, Healthacare Analytics, Digital Health Systems), by Component (Hardware, Software, Services), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)". The market size stood at USD 145.57 Billion in 2021.

WASHINGTON, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Behavioral Mental Health Software Market finds that rising government funding & initiatives to encourage EHR adoption in behavioural health organizations, favourable behavioural health reforms, rising adoption of behavioural health software and huge demand for mental health services are factors that influencing the growth of Behavioral Mental Health Software Market. The total Global Behavioral Mental Health Software Market is estimated to reach USD 5.20 Billion by 2028, up from USD 2.50 Billion in 2021, at a compound annual growth rate (CAGR) of 11.1%, states Vantage Market Research, in a report, titled " Behavioral Mental Health Software Market by Component Outlook (Support Services, Software), by Delivery Model Outlook (Ownership, Subscription), by Function Outlook (Clinical, Administrative, Financial), by End-Use (Payers, Patients, Providers), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Major players in the digital health market are Allscripts Healthcare Solutions Inc. , BioTelemetry Inc. , eClinicalWorks, iHealth Lab Inc, McKesson Corporation, Koninklijke Philips N. V, AT & T, Cisco Systems, Athenahealth Inc. Major players in the digital health market are Allscripts Healthcare Solutions Inc. , BioTelemetry Inc. , eClinicalWorks, iHealth Lab Inc, McKesson Corporation, Koninklijke Philips N. V, AT & T, Cisco Systems, Athenahealth Inc.

Allscripts Healthcare Solutions Inc (MDRX) shares closed today at 0.4% below its 52 week high of $21.58, giving the company a market cap of $2B. The stock is currently up 16.3% year-to-date, up 20.7% over the past 12 months, and up 79.3% over the past five years. This week, the Dow Jones Industrial Average rose 0.5%, and the S&P 500 rose 0.0%. Trading Activity Trading volume this week was 51.1% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1258.1% The company's stock price performance over the past 12 months beats the peer average by 267.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -111.6% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

These top-ranked stocks are likely to beat on bottom line in their next releases.

Stocks Analysis by Zacks Investment Research covering: Henry Schein Inc, Zimmer Biomet Holdings Inc, Allscripts Healthcare Solutions Inc, Healthcare Services Group Inc. Read Zacks Investment Research''s latest article on Investing.com